Details for New Drug Application (NDA): 022128
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in SELZENTRY is maraviroc. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the maraviroc profile page.
Summary for 022128
Tradename: | SELZENTRY |
Applicant: | Viiv Hlthcare |
Ingredient: | maraviroc |
Patents: | 2 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 022128
Mechanism of Action | Chemokine Co-receptor 5 Antagonists |
Suppliers and Packaging for NDA: 022128
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SELZENTRY | maraviroc | TABLET;ORAL | 022128 | NDA | ViiV Healthcare Company | 49702-223 | 49702-223-18 | 60 TABLET, FILM COATED in 1 BOTTLE (49702-223-18) |
SELZENTRY | maraviroc | TABLET;ORAL | 022128 | NDA | ViiV Healthcare Company | 49702-224 | 49702-224-18 | 60 TABLET, FILM COATED in 1 BOTTLE (49702-224-18) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
Approval Date: | Aug 6, 2007 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Feb 6, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
Patent: | ⤷ Try a Trial | Patent Expiration: | May 25, 2023 | Product Flag? | Substance Flag? | Delist Request? | Y |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Aug 6, 2007 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Feb 6, 2022 | Product Flag? | Substance Flag? | Delist Request? |
Expired US Patents for NDA 022128
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viiv Hlthcare | SELZENTRY | maraviroc | TABLET;ORAL | 022128-004 | Nov 4, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Viiv Hlthcare | SELZENTRY | maraviroc | TABLET;ORAL | 022128-003 | Nov 4, 2016 | ⤷ Try a Trial | ⤷ Try a Trial |
Viiv Hlthcare | SELZENTRY | maraviroc | TABLET;ORAL | 022128-002 | Aug 6, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
Viiv Hlthcare | SELZENTRY | maraviroc | TABLET;ORAL | 022128-001 | Aug 6, 2007 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription